Pc. Baker et al., The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections, ARCH PED AD, 155(2), 2001, pp. 135-139
Objective: To determine whether the addition of a single dose of ceftriaxon
e sodium to a 10-day course of trimethoprim and sulfamethoxazole hastens ur
ine sterilization or resolution of clinical symptoms in febrile children wi
th urinary tract infections.
Design: Prospective, single-blind, randomized study,
Setting: Tertiary care children's hospital emergency department.
Patients: Febrile children aged 6 months to 12 years with a presumptive uri
nary tract infection based on history, physical examination, and urinalysis
findings.
Interventions: A history was taken, a physical examination and urinalysis a
nd culture were performed, and a white blood cell count and erythrocyte sed
imentation rate were obtained. Children were randomized to receive an intra
muscular dose of ceftriaxone then 10 days of trimethoprim-sulfamethoxazole
(IM+PO group) or oral trimethoprim-sulfamethoxazole alone (PO group). After
receiving study medication, patients were discharged from the hospital to
return in 48 hours for a follow-up evaluation and urine culture. Treatment
failure was defined as the persistence of a positive culture at 48 hours or
the need for hospital admission for intravenous rehydration or antibiotic
therapy.
Results: Sixty-nine children were enrolled, 34 in the IM+PO group and 35 in
the PO group. The 2 groups were similar at the initial visit with respect
to age, sex, clinical degrees of illness, white blood cell count, and eryth
rocyte sedimentation rate (P>.05). At the 48-hour follow-up visit, there we
re no differences between the 2 treatment groups in resolution of vomiting,
fever, general appearance, abdominal tenderness, and hydration state (P>.0
5). There were 9 treatment failures, 4 in the IM+PO group and 35 in the PO
group (P=.93).
Conclusion: The addition of a single dose of intramuscular ceftriaxone to a
10-day course of oral trimethoprimsulfamethoxazole for urinary tract infec
tion with fever resulted in no difference at 48 hours in the urine steriliz
ation rate, degree of clinical improvement, or subsequent hospital admissio
n rate.